We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lon.Asia China | LSE:LCP | London | Ordinary Share | GB00B0XF7K04 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/9/2006 15:33 | So here is how it looks 25% stake in China New Energy bought for £2.2m M.cap at float = 35m. LCP stake profit = 35*0.25 - 2.2 = £6.55m 31% stake in China Biofoods bought for £2.1m M.cap at float = 12.5m LCP stake profit = 12.5*0.31 - 2.1 = £1.775m 10% stake in Mobile Net bought for £96800 M cap at float = £7.5m LCP stake profit = 7.5*0.10 - £96800= 0.6532m So Paper profit on the week a mighty £8.9782 m | robsy2 | |
06/9/2006 12:41 | China biofoods now confirmed for listing tomorrow | boonboon | |
06/9/2006 11:28 | Nice posts fellas and nice business for LDC and LCP. It all bode well for us shareholders. Looking at eth CNE float I see the directors have all awarded themselves lots of options. This should keep them interested as time goes on. RE; CNE " LACPEF has invested GBP 2.2 million in the Company which equates to a price of 127p per share. 650,000 options have been granted to directors and senior management to acquire ordinary shares at 150p per share. A further 700,000 options have been granted to directors and senior management to acquire ordinary shares at 525p per share." If they ever get to exercise them then we will all be laughing. I remain bullish of the whole thing and especailly the warrants on the LCP fund see LCPW. | robsy2 | |
06/9/2006 08:13 | LCP have invested in 5 companies 2 of which have now listed with a 3rd expected any day now. They invested £2million for a 19% stake in Dalian business institute which is now worth £3,354,013, based on the bid price. They invested £1.9million for a 25% stake in China new energy which at listing had a value of £8,584,710 based on the bid price. | boonboon | |
06/9/2006 08:09 | The latest RNS shows the following: 25% stake in China New Energy bought for £2.2m M.cap at float = 35m. LCP stake profit = 35*0.25 - 2.2 = £6.55m 31% stake in China Biofoods bought for £2.1m M.cap at float = 12.5m LCP stake profit = 12.5*0.31 - 2.1 = £1.775m At float prices that they've just made £8.325 million. And that's discounting all the other things like price rising, divis, etc. | amitkoth | |
06/9/2006 07:23 | China New Energy Limited select Overview Profile Contacts Reports & Accounts Offerings News Market Data Charts News China New Energy Limited - Start of trading CHINA NEW ENERGY LTD START OF TRADING The Directors of China New Energy Limited ("CNE" or "the Company") are pleased to announce that the Company's shares have commenced trading on PLUS today under the sector classification Speciality and Other Finance. The total number of ordinary 1p shares to be admitted to trading on PLUS is 6,733,106. The opening price is expected to be 525p per share. BUSINESS ACTIVITIES CNE, a newly incorporated Jersey company, has been established as an investment vehicle focusing on the rapidly expanding ethanol sector in China. The Company is seeking to acquire operational assets relating to the supply of turnkey technology solutions for the production of ethanol, edible alcohol and acetic acid from a range of bio-resources, including corn, sugarcane, cassava and other bio-resources in China. The Company aims to become a leading player in China's fuel ethanol market by: * Supplying equipment, engineering design, installation, and commissioning of ethanol production equipment; * After sales service for newly built and reformed factories; * Ownership of ethanol production facilities. The Directors have identified a number of opportunities which, in their opinion, will meet the Company's investment strategy. The Company has raised GBP 2.2 million from the London Asia Chinese Private Equity Fund ("LACPEF"). THE MARKET Fuelled by rapid economic growth, China has become a significant energy consumer, with its annual increase in energy consumption almost equal to the total installed capacity in the UK, and usage rising by 16% alone in 2004. Although China's oil consumption is the second highest in the world, it is still less than a third of that of the US, and less than 10% per head of that in the West. Demand growth in China accounted for 52% of global energy demand growth from 2002-2004. In 2005, China imported over 44% of its oil consumption and this is set to increase significantly as China's growth and manufacturing boom continues. The Chinese government is eager to reduce the country's reliance on oil imports and to increase the uptake of alternative fuels, both for economic, environmental and strategic defence reasons. It is therefore very supportive of the renewable energy sector. The Chinese government has enacted various laws and regulations encouraging the use of renewable energy as a substitute for fossil fuels, one of which states that vehicle fuel must comprise at least 10% fuel ethanol in 11 of the 33 provinces in China. This creates a new market for ethanol production, as previously only one province was operating a trial system. As more provinces start to implement this policy, China is likely to face a significant shortage in fuel ethanol. According to the National Development and Reform Committee, the demand for fuel ethanol in the next five years will reach 5-7 million tonnes annually, whilst fuel ethanol production in 2005 was only 1.02 million tonnes. Hence the market size is expected to increase considerably, resulting in significant opportunities in the supply chain to the ethanol production market. FINANCIAL RESULTS AND SHAREHOLDERS CNE was incorporated in Jersey in May 2006 and has minimal trading to date. Significant shareholders are: LACPEF 25.0% Leader Vision Investment Limited 23.8% (Beneficial owner - Yu Weijun) Asia Tianxing Investment Limited 17.8% (Beneficial owner - Tang Zhaoxing) Best Full Investments Limited 17.8% (Beneficial owner - Liang Hongtao) Qiu Weiming 7.4% Jiang Xinchun 7.4% Directors' shareholdings in the Company are 41.6%. LACPEF has invested GBP 2.2 million in the Company which equates to a price of 127p per share. 650,000 options have been granted to directors and senior management to acquire ordinary shares at 150p per share. A further 700,000 options have been granted to directors and senior management to acquire ordinary shares at 525p per share. REASONS FOR LISTING CNE is seeking to list its ordinary shares on PLUS in order to give it access to the UK's capital markets to fund future expansion. BOARD OF DIRECTORS Mr Yu Weijun - Chairman Mr. Yu, founder of the Company, is the former deputy chief of Guangzhou Energy Institute of the China Academy of Sciences (CAS) the leading research centre in China and has considerable experience in the fuel ethanol sector in China. Mr. Yu is very experienced in the management of engineering companies, finance and accounting. He has an EMBA from Sun Yat-sen University. Mr Tang Zhaoxing - Executive Director Mr. Tang is a Senior Engineer. He studied in the chemical faculty of the South China University of Science & Technology. He is responsible for the development and implementation of the technology for ethanol and its derived products, equipment supply, technical services and R&D. He has 15 years experience in the ethanol industry, and over 10 years experience in company management. He has an EMBA from Peking University and a Master of Sciences. Mr Simon Littlewood - Non-Executive Director Simon is a co-founder and the Chief Executive of London Asia Capital plc ("London Asia"). After qualifying as a Chartered Accountant with Coopers & Lybrand, London (now PwC) where he specialised in high growth companies, he joined the structured and corporate finance division of the HSBC Group in London. In 1995, he moved to BDO Stoy Hayward's corporate finance team, where he advised on AIM flotations, mergers and acquisitions and fund raisings, leaving in 1996 to set up the Temima Group, an investment and corporate finance business. In 2002 he took over an AIM listed shell which he converted into London Asia. He has experience of working on transactions in the UK, Germany, Eastern Europe, France, the US, Israel, China, Malaysia, Taiwan and Singapore. He is a director of AIM listed Europasia Education plc and London Asia Chinese Private Equity Fund, a number of private companies and represents London Asia on the boards of several of its investee companies, including PLUS listed China Education Group, China Eastsea Business Software and Peach Blossom Media. Simon graduated in Law from Oxford University and is authorised by the UK's Financial Services Authority. Victor Ng - Non-Executive Director Victor is a co-founder and executive director of London Asia Capital plc. A former principal with KPMG Singapore, he has funded, advised and launched several start-ups as well as later stage companies including several which were subsequently listed in Singapore, Malaysia, New York and London. Victor is currently a director of several China and Asia-Pacific-focused companies including Singapore listed Asia Water and Asia Power Corp Limited, UK AiM listed Europasia Education Limited and London Asia Chinese Private Equity Fund, and PLUS traded China Education Group, Peach Blossom Media Limited, China Biotech Healthcare limited and Dalian Business Institute. RISK FACTORS In addition to the usual risks associated with investing in small, high growth businesses, the Company faces the following specific risks: * The Company intends to invest, or make an acquisition, in the ethanol industry in China. Consequently the Company's future prospects will be dependent on commodity prices and the availability of raw material supplies which are subject to significant volatility and uncertainty. * The China ethanol industry is dependent upon a myriad of Chinese government legislation and regulation and any adverse changes in legislation or regulation could materially affect the Company's results, operations and financial position. * The Ordinary Shares will not be listed or dealt in on any stock exchange. Notwithstanding the fact the Ordinary Shares are to be traded on PLUS, this should not be taken as implying that there will be a "liquid" market in the Ordinary Shares. An investment in the Ordinary Shares may thus be difficult to realise. The value of the Ordinary Shares may go down as well as up. Investors may therefore realise less than their original investment or sustain a total loss of their investment. * It may be necessary for the Company to raise additional capital to progress through further stages of development. There can be no assurance that such funding, if required, will be made available to the Company. * The success of the Company will be dependent on the expertise and experience of the Directors. The loss of one or more could have a detrimental effect on the performance of the Company. * The Company's operations will be based substantially in China through subsidiary companies incorporated in China. Were there to be restrictions imposed on the movement of currency out of China, or depreciation in the Chinese currency, or a change in Chinese government, regulation or policies, it could have a significant impact on the Company. * The Company is incorporated in Jersey and has been granted tax exempt status in this jurisdiction. The Directors intend to maintain this status. Should any tax authority challenge this status the Directors intend to defend the Company's tax position. However, a successful challenge may result in the Company's profits being subject to applicable tax, which may be at a higher rate payable than under its current status. CORPORATE ADVISOR AND CONTACT DETAILS London Asia Corporate Finance Limited is acting as the Corporate Advisor for China New Energy Limited and can be contacted at: Stephen Lucas 4th Floor, 35 Park Lane London W1K 1RB Tel 020 7355 7928 Fax 020 7495 1691 Email: stephen.lucas@london For additional information, visit the Company's web site at www.chinanewenergygr Registered office: Ordnance House 31 Pier Road St Helier Jersey, Channel Islands JE4 8PW The Directors of China New Energy Limited accept responsibility for this announcement. DIRECTORSHIPS DIRECTOR CURRENT DIRECTORSHIPS PAST DIRECTORSHIPS Yu Weijun Guangdong Boluo Jiunen High & New Technology Engineering Co., Ltd. Guangzhou Zhongke Huangnen Science & Technology Co., Ltd. Guangzhou Zhongke Huayuan Science & Technology Co., Ltd. Guangdong Waste Environment Protection Engineering Co., Ltd. Guangzhou Ruipu Energy & Environmental Science & Technology Co., Ltd. Guangzhou Clean New Technology Co., Ltd. Guangzhou Zhongke Water Environment Protection Engineering Co., Ltd Boluo Solid Waste Treatment Co., Ltd. Leader Vision Investments Limited Tang Zhaoxing Tongliao Zhongke Tianyuan Amylum Chemical Co., Ltd Huaiji Zhongke Tianlun Industrial Co.,Ltd. Qinyuan Heli Huangnen Bio-engineering Co., Ltd Asia Tianxing Investment Limited Guangzhou Xinxing Tianyuan Investment Co., Ltd Simon Littlewood London Asia Capital plc Clean Technology plc Europasia Education plc Stunningview Ltd Simolit Ltd Temima Group plc Chesterhigh Ltd Outset Developments Ltd Justproperty.com Ltd China Education Group Ltd China Eastsea Business Software Ltd Peach Blossom Media Ltd China Financial Services Inc China Biotech Healthcare Ltd Temima China Investment Banking Services Co., Ltd London Asia Chinese Private Equity Fund Ltd China MobileNet Ltd Victor Ng AEC. Edu Group Pte Ltd Metro-City Asia Cable TV Pte Ltd Development Asia Development Organisation Ltd Corporation Pte Asia Power Corporation Ltd Ltd Asia Water Technology Ltd Temima Singapore Devotion Eco-Thermal Ltd Pte Ltd Europasia Education Plc Technical London Asia Capital Plc Training London Asia Capital Ltd Institute Mercur Business Control Asia Pte Ltd Australia The Nanyang Insurance Company Ltd Temima China Investment Banking Services Co., Ltd Temima Group Plc Savant Infocomme Pte Ltd Shandong Yuancheng Cable TV Co. Ltd China Financial Services Inc China Education Group Limited China Biotech Healthcare Ltd Peach Blossom Media Limited Dalian Business Institute Ltd London Asia Chinese Private Equity Fund Ltd China MobileNet Ltd | boonboon | |
01/9/2006 12:15 | Thanks all for the great thread. Very informative.I have leapt in this morning and bought the warrants. I've never bought a warrant in my life before but they looked good value at 26p giving me a buying in price of 1.46p at any time before 31-3-11.I'll eat my socks if this stock doesnt hit that sometime over the next 5 years. | robsy2 | |
22/8/2006 11:23 | They've no changed it Significant shareholders are: Ru Ji 30% Jianguo Zhang 20% Aijun Wang 10% Haipeng Fu 10% London Asia Chinese Private Equity Fund Ltd 10% Yan Xiong 8% Wenshu Wang 7% Genxi Li 5% | boonboon | |
22/8/2006 09:07 | so LCP have 10 % of the 118 % of China BIO then, boonboon | portly2 | |
21/8/2006 09:04 | Here's the next one. 21 August 2006 CHINA NEW ENERGY LTD APPLICATION ANNOUNCEMENT The Directors of China New Energy Limited ("CNE" or "the Company") are pleased to announce that the Company has applied to join PLUS via an introduction under the sector classification Speciality and Other Finance. The expected date of first trading is 6 September 2006. BUSINESS ACTIVITIES CNE, a newly incorporated Jersey company, has been established as an investment vehicle focusing on the ethanol sector. The Company is seeking to acquire operational assets relating to the supply of turnkey technology solutions for the production of ethanol, edible alcohol and acetic acid from a range of bio-resources, including corn, sugarcane, cassava and other bio-resources in China. The Company aims to become a leading player in China's fuel ethanol market by: · Supplying equipment, engineering design, installation, and commissioning of ethanol production equipment; · After sales service for newly built and reformed factories; · Ownership of ethanol production facilities. The Directors have identified a number of opportunities which, in their opinion, will meet the Company's investment strategy. The Company has raised GBP2.2 million from the London Asia Chinese Private Equity Fund ("LACPEF"). The Company has a strong and highly experienced management team. Mr. Yu Weijun, Chairman, is the former deputy chief of Guangzhou Energy Institute of the China Academy of Sciences, the leading research centre in China and has considerable experience in the fuel ethanol sector in China. He has an EMBA from Sun Yat-sen University. Mr. Tang Zhaoxing, Executive Director, is a Senior Engineer and studied in the chemical faculty of the South China University of Science & Technology. He has 15 years experience in the ethanol industry, including 10 years experience in company management, and is currently responsible for the development and implementation of the technology for ethanol and its derived products, equipment supply, technical services and R&D. He has an EMBA from Peking University and a Master of Sciences. Simon Littlewood and Victor Ng, Executive Directors of LACPEF, have joined the Company's board as non executive directors to assist in the development of the Company. THE MARKET Fuelled by rapid economic growth, China has become a significant energy consumer, with its annual increase in energy consumption almost equal to the total installed capacity in the UK, and usage rising by 16% alone in 2004. Although China's oil consumption is the second highest in the world, it is still less than a third of that of the US, and less than 10% per head of that in the West. Demand growth in China accounted for 52% of global energy demand growth from 2002-2004. In 2005, China imported over 44% of its oil consumption and this is set to increase significantly as China's growth and manufacturing boom continues. The Chinese government is eager to reduce the country's reliance on oil imports and to increase the uptake of alternative fuels, both for economic, environmental and strategic defence reasons. It is therefore very supportive of the renewable energy sector. The Chinese government has enacted various laws and regulations encouraging the use of renewable energy as a substitute for fossil fuels, one of which states that vehicle fuel must comprise at least 10% fuel ethanol in 11 of the 33 provinces in China. This creates a new market for ethanol production, as previously only one province was operating a trial system. As more provinces start to implement this policy, China is likely to face a significant shortage in fuel ethanol. According to the National Development and Reform Committee, the demand for fuel ethanol in the next five years will reach 5-7 million tonnes annually, whilst fuel ethanol production in 2005 was only 1.02 million tonnes. Hence the market size is expected to increase five fold, resulting in significant opportunities in the supply chain to the ethanol production market. FINANCIAL RESULTS AND SHAREHOLDERS CNE was incorporated in Jersey in May 2006 and has minimal trading to date. Significant shareholders are: Leader Vision Investment Limited 24% Asia Tianxing Investment Limited 18% Best Full Investments Limited 18% Qiu Weiming 7% Jiang Xinchun 7% LACPEF 25% The Directors of China New Energy Limited accept responsibility for this announcement. London Asia Corporate Finance Limited is acting as the Corporate Advisor for China New Energy Limited, and can be contacted at: Stephen Lucas 4th Floor, 35 Park Lane London W1K 1RB Tel 020 7355 7928 Fax 020 7495 1691 Email: info@londonasiacf.co | boonboon | |
21/8/2006 07:45 | China Biofoods Limited Type of Issue: Introduction CHINA BIOFOODS LIMITED APPLICATION ANNOUNCEMENT The Directors of China Biofoods Limited ("China Biofoods" or "the Company") are pleased to announce that the Company has applied for admission to PLUS under the Health sector classification. The expected date of first trading is 6 September 2006. BUSINESS ACTIVITIES China Biofoods, registered in Jersey, is the holding company of Henan Yuanhua Biotechnology Co., Ltd ("Yuanhua") based in Xuchang, Henan Province, the centre for farming traditional Chinese medical herbs. It specialises in the production of highly purified herb extract products, which are then used to produce traditional Chinese medicine, and as ingredients in functional foods. The market for "Functional Foods" - foods or dietary components that may provide a health benefit beyond their basic nutritional value - is expanding rapidly worldwide, especially in China. China Biofoods' core products are highly purified linolenic acids, Reshi mushroom spore oil and deodorized garlic oil, which collectively account for approximately 90% of its revenue. Produced from the purification of extracts from plant seeds, linolenic acids are extremely useful for healing and maintaining good health, but cannot be produced by the human body. Proven functions of linolenic acid include improving hair and skin, reducing blood pressure, helping prevent arthritis, lowering cholesterol and triglycerides and reducing the risk of blood clots. Highly purified linolenic acid is difficult for mass production due to its fragility when exposed to air during the production procedure. It accounts for nearly 50% of the Company's revenue and profit. According to an industry report, the market has an annual average growth rate of 10%. China Biofoods has a 25% market share in China for providing this product. Reshi is widely accepted in oriental cultures as a precious herb for strengthening the immune system. Scientific studies have showed strong anti-viral and anti-oxidant effects. Since reshi spore is the most active compound, reshi mushroom spore oil is broadly used in the health food industry as a supplement and intermediate ingredient. Garlic is a standard food supplement but normal garlic oil has an unpleasant flavour, which limits its applications. China Biofoods developed the technology to produce deflavoured garlic oil while maintaining all active compounds in garlic. The Company is in the process of launching a new product - high protein corn - and has formed an alliance with the world famous biotech research team led by Professor Niu Man Chiang, a Chinese American and world famous biologist. He graduated from Beijing University and obtained the PhD from the University of Stanford. He was awarded the 'American Man of Science', the Guggenheim Prize and the Lily Prize for his outstanding research in the bio-science arena. He is the founder of the 'Theory of Epigene'. His team developed a patented high protein corn which, because of its high nutritional and economic value, is believed to be the best choice for poverty-alleviation projects in China. In November 2005, Mr. Niu authorised China Biofoods to be the sole company breeding his patented high protein corn in China. The corn is integrated with soybean protein to deliver 4 times more protein than that of ordinary corn. It thus serves as a much better protein source for the feed meal and food industries. Mr. Niu is currently setting up a research centre within the Company to provide technical support for this new project implementation. KEY ASPECTS · Strong research and development capability and patented technology: · One of the few technology leaders in the industry, with 6 technology patents · Alliance with world famous biotech research team led by Professor Niu Man Chiang and leading Chinese Universities; · Existing range of health products in growing market: · 25% market share in market growing 10% pa (linolenic acids) · The first supplier of de-flavoured garlic oleoresin in China · Strong customer base · Well-developed sales network covering major cities in Greater China; · Strategic partnership with leading pharmaceutical companies; · New product pipeline - high protein corn; · Close to high quality raw materials farming base and partnership with herb planting farms; · Experienced management team THE MARKET The rapid growth of functional foods in China is due to the convergence of several factors. · It is being used by the government as a means to tackle malnutrition in underdeveloped, poverty-stricken regions of China. To address this problem, the Centre for Public Nutrition and Development of China, a government-sponsored institution, has in recent years proposed that some necessity foods should be fortified. The high-protein corn project being launched by China Biofoods is aiming to capture this opportunity. · Dietary problems have arisen as living standards have improved in the more developed parts of the country, especially in cities where consumers eat an increasingly unbalanced diet and have hectic, yet sedentary lifestyles with little time to exercise. The development of functional foods, like linolenic acid products, provides consumers with the opportunity to have a more balanced and nutritious diet. Currently, the key consumers of fortified and functional products are city dwellers living in such places as Shanghai and Guangzhou, as they tend to have higher nutrition awareness and greater media exposure to wellness products. · Consumer education in health and nutrition, coupled with increasing purchasing power, is expected to significantly contribute to the growth of the health foods market in general and the functional foods market in particular. · Ageing population. Affluent consumers in China and Hong Kong are increasingly looking for functional foods as a means to counter illnesses and increasing healthcare costs arising from unhealthy lifestyles and unbalanced diets, and longer life expectancy. FINANCIAL RESULTS AND SHAREHOLDERS China Biofoods was incorporated in Jersey in April 2006 so has minimal trading to date. The proforma results for Yuanhua to December 2005, which assumes that China Biofoods had been running the business for the 12 months then ended, shows turnover of GBP2.9 million and profits after tax of GBP1.1 million. Significant shareholders are: Ru Ji 30% Jianguo Zhang 24% Aijun Wang 24% Haipeng Fu 10% London Asia Chinese Private Equity Fund Ltd 10% Yan Xiong 8% Wenshu Wang 7% Genxi Li 5% The Directors of China Biofoods Limited accept responsibility for this announcement. London Asia Corporate Finance Limited is acting as the Corporate Advisor for China New Energy Limited, and can be contacted at: Stephen Lucas 4th Floor, 35 Park Lane London W1K 1RB Tel 020 7355 7928 Fax 020 7495 1691 Email: info@londonasiacf.co | boonboon | |
25/7/2006 10:57 | "In March we listed the London Asia Chinese Private Equity Fund ("the Fund") on AiM (code LCP), raising the full #50 million it was seeking. The Fund focuses on investments in private Chinese businesses, and has to date committed to make five investments, totalling #9.3 million, with another ten transactions currently going through final due diligence." from the LDC agm statement. | boonboon | |
30/6/2006 07:32 | Acquisition RNS Number:4253F London Asia Chinese Private Equity 30 June 2006 30 June 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Three new investments LACPEF, the China focused investment fund, announces that it has committed to make three new investments, for a total consideration of #6.9 million in cash. The Fund is investing #1.9 million in China New Energy Ltd ("CNE"), a leading turnkey provider of production equipment and technologies for ethanol production in China; #2.9 million in China Synergy Real Estate Limited ("Synergy"), a leading real estate services firm based in Beijing; and #2.1 million in China Biofoods, a health food products company. China New Energy: CNE's core business is the supply of turnkey technology solutions for the production of ethanol, edible alcohol and acetic acid from a range of bio-resources, including corn, sugarcane, cassava and other bio-resources. CNE has established itself as the leading brand in China, with an estimated 60% share of the market for ethanol production equipment in China. The Company's successful track record is key to growing the business and its leading technology has been used in over 30 projects. CNE is supported by strong drivers with the demand for ethanol, a fuel seen as an alternative to oil, still growing and supported by a new legislative framework requiring 10% of all vehicle oil consumption to be biofuel in 11 of China's Provinces. For the year ended 31 December 2005 CNE reported profit after tax of #1.9m (2004: #0.6m) on sales of #8.7m (2004: #3.1m). Based in Guangzhou, it was founded in June 2002 as a spin-out from the Renewable Energy division of China's Academy of Science, the leading Government funded centre in China for the development of renewable energy technology. CNE currently has 72 employees and following the investment from the fund, Simon Littlewood and Victor Ng, managers of the Fund, will take a seat on the Company's board. China Synergy: Synergy is the second largest real estate broker in the northern China market. Founded 10 years ago in Beijing, China, the Company provides agency, consultancy and conveyance services for property developers in China including international property investors Carlyle Partners and Lehman Bros. The Company focuses on deals with residential and commercial properties at the top end of the market, and has advised on 60 projects. Synergy was named as "Agency of the Year" in "New Real Estate", the industry magazine, and in the Top 20 Real Estate Agencies in China" in 2005 by "SINA.com ". For the year ended 31 December 2005 Synergy reported profit after tax of #2.1m on turnover of #4.9m, up 58% and 38% respectively on 2004. Simon Littlewood will be appointed to the Synergy Board following investment. China Biofoods: China Biofoods is based in Xuchang, Henan Province, the centre for farming traditional Chinese medical herbs. It specialises in the production of highly purified herb extract products which are then used to produce traditional Chinese medicine, and as ingredients in functional foods. The market for "Functional Foods" is expanding rapidly worldwide, especially in China. "Functional Foods" are foods or dietary components that may provide a health benefit beyond their basic nutritional value. China Biofoods' core products are highly purified linolenic acids, Reshi mushroom spore oil, and deodorized garlic oil. Linolenic acid, also known as Vitamin F, is an essential fatty acid which is not produced by the body, and has been proven to improve hair and skin, reduce blood pressure, help prevent arthritis, lower cholesterol & triglycerides and reduce the risk of blood clots. Reshi mushroom spore oil is broadly used in the health food industry as a supplement and intermediate ingredient. In 2005 China Biofoods reported revenues of #2.9m with profit after tax of #1.2m. The Fund will appoint a representative to the China Biofoods Board following investment. Victor Ng, Director of LACPEF, commented: "All three companies presented at London Asia's China Seminar in London earlier this month. There was strong interest from investors as all three sectors are showing considerable growth on the back of China's continued economic development. CNE is the leading player in is field and has significant growth potential as China seeks to develop renewable energy sources and reduce its reliance on expensive imported fossil fuels. Synergy is taking advantage of the switch from public and subsidised housing to the development of a private housing market in China, with the Beijing market seeing additional impetus from the 2008 Olympics. China Biofoods' products appeal to the increasingly affluent Chinese population, who have more money to spend than in the past and are becoming more health conscious, particularly as a result of the one child policy and the ageing of the population" Simon Littlewood, Director of LACPEF, added: "The Fund has now made five investments, totalling #9.3 million. There is potential to make follow on investments in those deals as the companies develop and we also have a number of other deals which we expect to close in the near future." For further information please visit www.londonasiafunds. John West/Matt Ridsdale Simon Littlewood Hugh Field Tavistock Communications London Asia Capital plc Collins Stewart Limited Tel: 020 7920 3150 Tel: 020 7355 7928 Tel: 020 7523 8000 This information is provided by RNS The company news service from the London Stock Exchange END ACQFLMRTMMATBFF | boonboon | |
07/6/2006 07:28 | One of it's first 2 investments Dalian business institute has now been floated on Ofex. The fund's 19% stake is now worth about £3.9million not bad considering they only paid £2million for it less than a month ago. Their second investment company Fsnet is due to float on ofex this month so hopefully we should see about the same return on that. | boonboon | |
03/6/2006 14:49 | John Manser, Chairman, speaking at the London Asia China seminar on 14 June so should be some news then | painting | |
16/5/2006 21:21 | 15 May 2006 EUROPASIA EDUCATION DBI Interim Results show strong growth Europasia Education plc's ("EPE") investee company, Dalian Business Institute Ltd ("DBI"), today released interim results for the six months ended 31 January 2006 showing turnover of £1.0 million, and post tax profits of £0.9 million, up 13.1% on the comparative period in 2005. DBI is a Jersey incorporated company with a 25 year contract for the management of Dalian Business Institute in Liaoning Province, China ("DBIC"). DBI is in the process of applying for admission to Ofex, with trading expected to commence on 23 May. DBI announced last week that it had successfully raised £1.5 million to fund expansion of its facilities to meet demand for its courses. Following the fund raising, EPE's stake in DBI is 10.8%. Mr Zhang Wenchao, President of DBIC, said: "We continue to see strong demand for our programs, reflected in the increased profits for the six months to January 2006. Once admitted to Ofex, we will look both to expand organically, through additional courses and increased facilities, and via acquisition, using the funds raised and the strong cash flows generated by the business." James Holmes, EPE Chairman, said: "We invested £1.1 million for a stake in DBI, which should show a significant uplift when the company is admitted to Ofex in the next two weeks." For further information, contact: Paul Quade City Road Communications Tel 020 7248 8010 James Holmes Europasia Education plc Tel 020 7248 7578 About Dalian Business Institute China DBIC is located in Dalian city, Liaoning Province. Founded in 1997, DBIC is a nationally accredited comprehensive three-year college focusing on business and arts subjects. There are currently over 5,000 students, based in the campus in Liaoning Province, China. There are 6 colleges and 5 faculties on the site, providing 3-year diploma and distance learning courses in 8 specific areas: Business Management; International Trade; International Accounting & Finance; Information Technology; International Tourism; Foreign Languages; Business Laws; and Arts. The college diplomas awarded by DBI are recognised by the Ministry of Education (MOE), the government authority of China. In China, only a degree or diploma granted by a university or college accredited by the Ministry of Education can be recognised officially in the nation. DBI is also working with local renowned public universities, such as Bohai University & Dalian University of Technology, to provide additional 1-2 year courses leading to bachelor's degree from those partnership universities. | boonboon | |
11/5/2006 08:22 | Been in this from the outset. Patiently waiting. I particularly liked the statements about more announcements to come. Sure they will since this was the whole point of the fund.......... "John Manser, Chairman of LACPEF said: 'Investor response to the fund has been strong and so it is particularly pleasing that we are announcing our first two investments. The managers have sourced promising investment opportunities and we look forward to announcing further investments in due course.' Simon Littlewood, Executive Director of LACPEF, commented: 'Following the raising of the Fund in March, we have spent the last six weeks finalising the investment terms on a number of transactions for the Fund, with these the first two to reach closure. Both are established, profitable businesses with good growth prospects in expanding sectors in China.'" | silverthread | |
11/5/2006 08:09 | The Dalian business institute deal could see a near instant return as it's planning to float on ofex in less than 2 weeks time. | boonboon | |
11/5/2006 08:04 | i'm in this now for a small punt. The bulk of funds is in LDC, but they first 2 deals are hopefully the start of many and it should bring the fund to peoples attention. Both deals seem to be at around 5 x earnings which is really good. | boonboon | |
09/5/2006 12:16 | I can easily see the net asset value of lcp increasing dramatically over 5 years. The warrants are interesting | gagner2006 | |
09/5/2006 12:14 | so lcp will need to be 150p for a profit Yes, but obviously if the LCP price were 151 in five years, buying LCP would be better because the profit on LCPW is lower. There is a year 2011 price at which buying LCPW becomes more profitable than LCP per pound invested, possibly around 170 if some quick mental calculations are correct - I'd have to put the figures into a spreadsheet later to verify that. After that, the profits from LCPW grow exponentially more than an equivalent position LCP. The downside is they may expire worthless so the risk is much greater. The warrants should follow the shareprice of LCP fairly closely, but there is an time decay factor as the expiry nears. Movements in LCPW of course, will be greater than LCP. | kamitora | |
09/5/2006 11:48 | thx, found that. In effect warrants to 2011 to subcribe for lcp share at 120p, currently costing 30p so lcp will need to be 150p for a profit. I think the warrants may follow the share price of lcp down, so a good investment but perhaps not immediately. What do you think Kam?? | gagner2006 | |
09/5/2006 11:43 | The LCP RNS I posted has a summary and the detail is on page 27 of the prospectus - there's a link to that in the header. | kamitora | |
09/5/2006 11:37 | kam thx my system was going do lalley b4 when I typed in lcpw got it now. what are the broad terms of the warrants | gagner2006 | |
09/5/2006 11:36 | Yes, LCPW is the epic. | kamitora |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions